Ananthi Rathinam
Neurology with Special Qualifications in Child Neurology · Orlando, FLNPI 1811952443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $688 and has fallen 76.7% since, to $160 in 2025. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in FL, where the typical reported total is $2,700.
Across 149 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$544
- Sunovion Pharmaceuticals Inc.$428
- UCB, Inc.$265
- Corium, LLC$185
- Greenwich Biosciences, Inc.$174
- Takeda Pharmaceuticals U.S.A., Inc.$137
- plus $967 from 21 others
What the payments were for
- Food & beverage$2,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 50 | $544 |
| Sunovion Pharmaceuticals Inc. | 20 | $428 |
| UCB, Inc. | 8 | $265 |
| Corium, LLC | 3 | $185 |
| Greenwich Biosciences, Inc. | 9 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| AbbVie(2 entities) | 7 | $108 |
| Livanova USA, Inc. | 5 | $95 |
| Neurelis, Inc. | 5 | $90 |
| Eisai Inc. | 4 | $84 |
| Jazz Pharmaceuticals Inc. | 3 | $67 |
| Cranial Technologies, Inc | 4 | $62 |
| Zogenix Inc. | 3 | $59 |
| Ironshore Pharmaceuticals Inc. | 3 | $51 |
| Shire North American Group Inc | 2 | $43 |
| Novartis | 2 | $43 |
| Tris Pharma Inc | 2 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $39 |
| Adlon Therapeutics L.p. | 2 | $30 |
| Catalyst Pharmaceuticals, Inc. | 1 | $28 |
| Biomarin Pharmaceutical Inc. | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| PTC Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$122
How this compares
$2,700 in reported general payments places this provider in the 50th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Orlando
- Omer Abdul HamidOrlando$283K
- Ngoc Minh leOrlando$19K
- Vikram PrakashOrlando$15K
- Ki-Hyeong LeeOrlando$15K
- Sheila Ramos MartinezOrlando$8K
- Anthony GiordanoOrlando$7K
- Murtuza KothawalaOrlando$5K
- Carl BarrOrlando$5K
- Dina DahanOrlando$5K
- Antonio Vazquez-DiazOrlando$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.